Verzenio Market: A Deep Dive into Its Expanding Role in Breast Cancer Treatment

The Verzenio market has emerged as a critical segment within oncology, with abemaciclib gaining widespread recognition for its effectiveness in treating breast cancer. As one of the leading CDK4/6 inhibitors, Verzenio is increasingly prescribed for p...